BostonPremier Wealth’s Merck MRK Stock Holding History

BostonPremier Wealth’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$218K	Buy	+1,499	New	+$207K	0.09%	77

Other funds holding MRK

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

BostonPremier Wealth's MRK Position: Q3 2026 in Review

BostonPremier Wealth opened a new position in Merck (MRK) in Q3 2026: 1,499 shares worth $218K. The stake represents 0.09% of the portfolio and ranks #77 among its holdings.

2,771 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

BostonPremier Wealth held 1,499 shares of Merck worth $218K as of Q3 2026.
Merck was a new BostonPremier Wealth position in Q3 2026.
Merck made up 0.09% of BostonPremier Wealth's portfolio in Q3 2026, its #77 holding.
2,771 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on BostonPremier Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.